K20 Potassium
Natural health product licensed in Canada
- Licence holder
- Altamed Pharma
- NPN or DIN-HM
- 80040412
- Status
- Active licence
- Licence date
- 27 February 2013
- Revision date
- 12 March 2025
- Form
- Comprimé à libération progressive
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Glycérine, Stéarate de magnésium, Macrogol 6 000, Hypromellose, Alcool isopropylique, Dispersion de copolymère d'ammonio méthacrylate, Gomme de xanthane, Chlorure de méthylène, Talc, Polyvinylpyrrolidone, Phosphate de calcium, dibasique, Dioxyde de titane
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | minimum: 1 Comprimé ; maximum: 2 Comprimé | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Supplément de potassium pour le traitement ou la prévention de l'hypokaliémie (déficit en potassium) non attribuable à une carence alimentaire. Traitement de remplacement du potassium. Traitement pour la recharge électrolytique.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80040412
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.